The Boundless team has grown to 28 employees in the company’s first two years. (Boundless Photo) In the two years since it launched, Boundless has become the top destination for immigrants applying ...
Boundless Bio’s announcement earlier this month of plans to go public was a sign that the biotech IPO window hadn’t slammed shut after a flurry of offerings at the start of the year. Now, the company ...
SEATTLE, October 01, 2025--(BUSINESS WIRE)--Boundless Immigration, the leading force for change in global immigration and workforce mobility, today announced its acquisition of Localyze, a premier ...
SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
Targeted therapies and immunotherapies offer new treatment options for more types of cancer, but these drugs are less helpful when tumors produce multiple copies of a gene. This gene amplification ...
A Quick Take On Boundless Bio, Inc. Boundless Bio, Inc. (BOLD) has filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement, although the final figure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results